ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Nixon Signs Training Grant Bill; No Action Yet On Cancer Act Renewal

July 19, 1974

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990

St. Jude Begins $100 Million Expansion Program

December 4, 1987